Skip to main content
Erschienen in: Neurotoxicity Research 4/2014

01.05.2014 | Original Article

Valproate Disturbs the Balance Between Branched and Aromatic Amino Acids in Rats

verfasst von: Piotr Maciejak, Janusz Szyndler, Karolina Kołosowska, Danuta Turzyńska, Alicja Sobolewska, Jerzy Walkowiak, Adam Płaźnik

Erschienen in: Neurotoxicity Research | Ausgabe 4/2014

Einloggen, um Zugang zu erhalten

Abstract

We investigated the effect of valproate (ip, 500 mg/kg), which is regarded as a potent plasma protein tryptophan (TRP) displacer, on the central nervous system (hippocampal) and peripheral (plasma) levels of the aromatic amino acids (AAAs; e.g. TRP, tyrosine and phenylalanine) and branched-chain amino acids (BCAAs; e.g. valine, isoleucine and leucine) as well as the other amino acids (glutamate, GABA, alanine, glutamine, glycine, aspartate and taurine) involved in the regulation of neurotransmission. Furthermore, we investigated whether the changes in the BCAA/AAA ratio affected the hippocampal concentration of monoamines [serotonin (5-HT), dopamine (DA) and noradrenaline (NA)]. Valproic acid (VPA) administration potently modified the balance between the BCAA and AAA. In the brain, the significantly increased AAA and decreased BCAA concentrations were followed by a decrease in the BCAA/AAA ratio. In the plasma, VPA significantly decreased the BCAA and AAA levels. The changes in the BCAA and AAA levels were accompanied by an increase in the NA, DA and 5-HT levels as well as hippocampal 5-HT metabolism. This novel finding indicates that VPA, through the displacement of TRP from its protein-binding sites, could disturb the BCAA/AAA ratio, with central nervous system consequences, including the possible contribution to VPAs effects in affective disorders.
Literatur
Zurück zum Zitat Anderson GD, Acheampong AA, Levy RH (1994) Interaction between valproate and branched-chain amino acid metabolism. Neurology 44(4):742–744PubMedCrossRef Anderson GD, Acheampong AA, Levy RH (1994) Interaction between valproate and branched-chain amino acid metabolism. Neurology 44(4):742–744PubMedCrossRef
Zurück zum Zitat Baf MH, Subhash MN, Lakshmana KM, Rao BS (1994) Sodium valproate induced alterations in monoamine levels in different regions of the rat brain. Neurochem Int 24(1):67–72PubMedCrossRef Baf MH, Subhash MN, Lakshmana KM, Rao BS (1994) Sodium valproate induced alterations in monoamine levels in different regions of the rat brain. Neurochem Int 24(1):67–72PubMedCrossRef
Zurück zum Zitat Baltes S, Fedrowitz M, Tortós CL, Potschka H, Löscher W (2007) Valproic acid is not a substrate for P-glycoprotein or multidrug resistance proteins 1 and 2 in a number of in vitro and in vivo transport assays. J Pharmacol Exp Ther 320:331–343PubMedCrossRef Baltes S, Fedrowitz M, Tortós CL, Potschka H, Löscher W (2007) Valproic acid is not a substrate for P-glycoprotein or multidrug resistance proteins 1 and 2 in a number of in vitro and in vivo transport assays. J Pharmacol Exp Ther 320:331–343PubMedCrossRef
Zurück zum Zitat Biggs CS, Pearce BR, Fowler LJ, Whitton PS (1992) Regional effects of sodium valproate on extracellular concentrations of 5-hydroxytryptamine, dopamine, and their metabolites in the rat brain: an in vivo microdialysis study. J Neurochem 59(5):1702–1708PubMedCrossRef Biggs CS, Pearce BR, Fowler LJ, Whitton PS (1992) Regional effects of sodium valproate on extracellular concentrations of 5-hydroxytryptamine, dopamine, and their metabolites in the rat brain: an in vivo microdialysis study. J Neurochem 59(5):1702–1708PubMedCrossRef
Zurück zum Zitat Bixel MG, Hutson SM, Hamprecht B (1997) Cellular distribution of branched-chain amino acid aminotransferase isoenzymes among rat brain glial cells in culture. J Histochem Cytochem 45(5):685–694PubMedCrossRef Bixel MG, Hutson SM, Hamprecht B (1997) Cellular distribution of branched-chain amino acid aminotransferase isoenzymes among rat brain glial cells in culture. J Histochem Cytochem 45(5):685–694PubMedCrossRef
Zurück zum Zitat Chaplin ER, Goldberg AL, Diamond I (1976) Leucine oxidation in brain slices and nerve endings. J Neurochem 26(4):701–707PubMedCrossRef Chaplin ER, Goldberg AL, Diamond I (1976) Leucine oxidation in brain slices and nerve endings. J Neurochem 26(4):701–707PubMedCrossRef
Zurück zum Zitat Coppola A, Wenner BR, Ilkayeva O, Stevens RD, Maggioni M, Slotkin TA, Levin ED, Newgard CB (2013) Branched-chain amino acids alter neurobehavioral function in rats. Am J Physiol Endocrinol Metab 304(4):405–413CrossRef Coppola A, Wenner BR, Ilkayeva O, Stevens RD, Maggioni M, Slotkin TA, Levin ED, Newgard CB (2013) Branched-chain amino acids alter neurobehavioral function in rats. Am J Physiol Endocrinol Metab 304(4):405–413CrossRef
Zurück zum Zitat Dam G, Ott P, Aagaard NK, Vilstrup H (2013) Branched-chain amino acids and muscle ammonia detoxification in cirrhosis. Metab Brain Dis 28(2):217–220PubMedCrossRef Dam G, Ott P, Aagaard NK, Vilstrup H (2013) Branched-chain amino acids and muscle ammonia detoxification in cirrhosis. Metab Brain Dis 28(2):217–220PubMedCrossRef
Zurück zum Zitat Dejong CH, van de Poll MC, Soeters PB, Jalan R, Olde Damink SW (2007) Aromatic amino acid metabolism during liver failure. J Nutr 137(6 Suppl 1):1579–1585 Dejong CH, van de Poll MC, Soeters PB, Jalan R, Olde Damink SW (2007) Aromatic amino acid metabolism during liver failure. J Nutr 137(6 Suppl 1):1579–1585
Zurück zum Zitat Fernstrom JD (1990) Aromatic amino acids and monoamine synthesis in the central nervous system: influence of the diet. J Nutr Biochem 1:508–517PubMedCrossRef Fernstrom JD (1990) Aromatic amino acids and monoamine synthesis in the central nervous system: influence of the diet. J Nutr Biochem 1:508–517PubMedCrossRef
Zurück zum Zitat Fernstrom JD (2005) Branched-chain amino acids and brain function. J Nutr 135(6 Suppl):1539–1546 Fernstrom JD (2005) Branched-chain amino acids and brain function. J Nutr 135(6 Suppl):1539–1546
Zurück zum Zitat Fischer JE, Yoshimura N, Aguirre A, James JH, Cummings MG, Abel RM, Deindoerfer F (1974) Plasma amino acids in patients with hepatic encephalopathy. Effects of amino acid infusions. Am J Surg 127:40–47PubMedCrossRef Fischer JE, Yoshimura N, Aguirre A, James JH, Cummings MG, Abel RM, Deindoerfer F (1974) Plasma amino acids in patients with hepatic encephalopathy. Effects of amino acid infusions. Am J Surg 127:40–47PubMedCrossRef
Zurück zum Zitat Gamberino WC, Berkich DA, Lynch CJ, Xu B, LaNoue KF (1997) Role of pyruvate carboxylase in facilitation of synthesis of glutamate and glutamine in cultured astrocytes. J Neurochem 69(6):2312–2325PubMedCrossRef Gamberino WC, Berkich DA, Lynch CJ, Xu B, LaNoue KF (1997) Role of pyruvate carboxylase in facilitation of synthesis of glutamate and glutamine in cultured astrocytes. J Neurochem 69(6):2312–2325PubMedCrossRef
Zurück zum Zitat Herve C, Beyne P, Jamault H, Delacoux E (1996) Determination of tryptophan and its kynurenine pathway metabolites in human serum by high-performance liquid chromatography with simultaneous ultraviolet and fluorimetric detection. J Chromatogr B 675(1):157–161CrossRef Herve C, Beyne P, Jamault H, Delacoux E (1996) Determination of tryptophan and its kynurenine pathway metabolites in human serum by high-performance liquid chromatography with simultaneous ultraviolet and fluorimetric detection. J Chromatogr B 675(1):157–161CrossRef
Zurück zum Zitat Hod G, Chaouat M, Haskel Y, Lernau OZ, Nissan S, Mayer M (1982) Ammonia uptake by skeletal muscle in the hyperammonaemic rat. Eur J Clin Investig 12(6):445–450CrossRef Hod G, Chaouat M, Haskel Y, Lernau OZ, Nissan S, Mayer M (1982) Ammonia uptake by skeletal muscle in the hyperammonaemic rat. Eur J Clin Investig 12(6):445–450CrossRef
Zurück zum Zitat Holecek M (2010) Three targets of branched-chain amino acid supplementation in the treatment of liver disease. Nutrition 26(5):482–490PubMedCrossRef Holecek M (2010) Three targets of branched-chain amino acid supplementation in the treatment of liver disease. Nutrition 26(5):482–490PubMedCrossRef
Zurück zum Zitat Hutson SM, Lieth E, LaNoue KF (2001) Function of leucine in excitatory neurotransmitter metabolism in the central nervous system. J Nutr 131(3):846–850 Hutson SM, Lieth E, LaNoue KF (2001) Function of leucine in excitatory neurotransmitter metabolism in the central nervous system. J Nutr 131(3):846–850
Zurück zum Zitat James JH (2002) Branched chain amino acids in hepatic encephalopathy. Am J Surg 183(4):424–429PubMedCrossRef James JH (2002) Branched chain amino acids in hepatic encephalopathy. Am J Surg 183(4):424–429PubMedCrossRef
Zurück zum Zitat James JH, Ziparo V, Jeppsson B, Fischer JE (1979) Hyperammonaemia, plasma aminoacid imbalance, and blood–brain aminoacid transport: a unified theory of portal-systemic encephalopathy. Lancet 2(8146):772–775PubMedCrossRef James JH, Ziparo V, Jeppsson B, Fischer JE (1979) Hyperammonaemia, plasma aminoacid imbalance, and blood–brain aminoacid transport: a unified theory of portal-systemic encephalopathy. Lancet 2(8146):772–775PubMedCrossRef
Zurück zum Zitat Kaneda N, Asano M, Nagatsu T (1986) Simple method for simultaneous determination of acetylcholine, choline, noradrenaline, dopamine and serotonin in brain tissue by high-performance liquid chromatography with electrochemical detection. J Chromatogr 360:211–218PubMedCrossRef Kaneda N, Asano M, Nagatsu T (1986) Simple method for simultaneous determination of acetylcholine, choline, noradrenaline, dopamine and serotonin in brain tissue by high-performance liquid chromatography with electrochemical detection. J Chromatogr 360:211–218PubMedCrossRef
Zurück zum Zitat Kelly KM, Gross RA, Macdonald RL (1990) Valproic acid selectively reduces the low-threshold (T) calcium current in rat nodose neurons. Neurosci Lett 116(1–2):233–238PubMedCrossRef Kelly KM, Gross RA, Macdonald RL (1990) Valproic acid selectively reduces the low-threshold (T) calcium current in rat nodose neurons. Neurosci Lett 116(1–2):233–238PubMedCrossRef
Zurück zum Zitat Kostrouchova M, Kostrouch Z, Kostrouchová M (2007) Valproic acid, a molecular lead to multiple regulatory pathways. Folia Biol 53(2):37–49 Kostrouchova M, Kostrouch Z, Kostrouchová M (2007) Valproic acid, a molecular lead to multiple regulatory pathways. Folia Biol 53(2):37–49
Zurück zum Zitat Kulick SK, Kramer DA (1993) Hyperammonemia secondary to valproic acid as a cause of lethargy in a postictal patient. Ann Emerg Med 22(3):610–612PubMedCrossRef Kulick SK, Kramer DA (1993) Hyperammonemia secondary to valproic acid as a cause of lethargy in a postictal patient. Ann Emerg Med 22(3):610–612PubMedCrossRef
Zurück zum Zitat Lang AP, de Angelis L (2003) Experimental anxiety and antiepileptics: the effects of valproate and vigabatrin in the mirrored chamber test. Methods Find Exp Clin Pharmacol 25(4):265–271PubMedCrossRef Lang AP, de Angelis L (2003) Experimental anxiety and antiepileptics: the effects of valproate and vigabatrin in the mirrored chamber test. Methods Find Exp Clin Pharmacol 25(4):265–271PubMedCrossRef
Zurück zum Zitat Leweling H, Breitkreutz R, Behne F, Staedt U, Striebel JP, Holm E (1996) Hyperammonemia-induced depletion of glutamate and branched-chain amino acids in muscle and plasma. J Hepatol 25(5):756–762PubMedCrossRef Leweling H, Breitkreutz R, Behne F, Staedt U, Striebel JP, Holm E (1996) Hyperammonemia-induced depletion of glutamate and branched-chain amino acids in muscle and plasma. J Hepatol 25(5):756–762PubMedCrossRef
Zurück zum Zitat Löscher W (2002) Basic pharmacology of valproate: a review after 35 year of clinical use for the treatment of epilepsy. CNS Drugs 16:669–694PubMedCrossRef Löscher W (2002) Basic pharmacology of valproate: a review after 35 year of clinical use for the treatment of epilepsy. CNS Drugs 16:669–694PubMedCrossRef
Zurück zum Zitat Löscher W, Horstermann D (1994) Differential effects of vigabatrin, γ-acetylenic GABA, aminooxyacetic acid, and valproate on levels of various amino acids in rat brain regions and plasma Naunyn–Schmiedeberg’s. Arch Pharmacol 349:270–278CrossRef Löscher W, Horstermann D (1994) Differential effects of vigabatrin, γ-acetylenic GABA, aminooxyacetic acid, and valproate on levels of various amino acids in rat brain regions and plasma Naunyn–Schmiedeberg’s. Arch Pharmacol 349:270–278CrossRef
Zurück zum Zitat Löscher W, Siemes H (1984) Valproic acid increases gamma-aminobutyric acid in CSF of epileptic children. Lancet 2(8396):225PubMedCrossRef Löscher W, Siemes H (1984) Valproic acid increases gamma-aminobutyric acid in CSF of epileptic children. Lancet 2(8396):225PubMedCrossRef
Zurück zum Zitat Maciejak P, Szyndler J, Turzyńska D, Sobolewska A, Płaźnik A (2011) Kynurenic acid: a new effector of valproate action? Pharmacol Rep 63(6):1569–1573PubMedCrossRef Maciejak P, Szyndler J, Turzyńska D, Sobolewska A, Płaźnik A (2011) Kynurenic acid: a new effector of valproate action? Pharmacol Rep 63(6):1569–1573PubMedCrossRef
Zurück zum Zitat Maciejak P, Szyndler J, Turzyńska D, Sobolewska A, Kołosowska K, Lehner M, Płaźnik A (2013) The kynurenine pathway: a missing piece in the puzzle of valproate action? Neuroscience 234:135–145PubMedCrossRef Maciejak P, Szyndler J, Turzyńska D, Sobolewska A, Kołosowska K, Lehner M, Płaźnik A (2013) The kynurenine pathway: a missing piece in the puzzle of valproate action? Neuroscience 234:135–145PubMedCrossRef
Zurück zum Zitat Morland C, Nordengen K, Gundersen V (2012) Valproate causes reduction of the excitatory amino acid aspartate in nerve terminals. Neurosci Lett 527(2):100–104PubMedCrossRef Morland C, Nordengen K, Gundersen V (2012) Valproate causes reduction of the excitatory amino acid aspartate in nerve terminals. Neurosci Lett 527(2):100–104PubMedCrossRef
Zurück zum Zitat Nilsson M, Hansson E, Rönnbäck L (1992) Interactions between valproate, glutamate, aspartate, and GABA with respect to uptake in astroglial primary cultures. Neurochem Res 17(4):327–332PubMedCrossRef Nilsson M, Hansson E, Rönnbäck L (1992) Interactions between valproate, glutamate, aspartate, and GABA with respect to uptake in astroglial primary cultures. Neurochem Res 17(4):327–332PubMedCrossRef
Zurück zum Zitat Okuno A, Fukuwatari T, Shibata K (2011) High tryptophan diet reduces extracellular dopamine release via kynurenic acid production in rat striatum. J Neurochem 118(5):796–805PubMedCrossRef Okuno A, Fukuwatari T, Shibata K (2011) High tryptophan diet reduces extracellular dopamine release via kynurenic acid production in rat striatum. J Neurochem 118(5):796–805PubMedCrossRef
Zurück zum Zitat Oldendorf WH (1971) Brain uptake of radiolabeled amino acids, amines, and hexoses after arterial injection. Am J Physiol 221(6):1629–1639PubMed Oldendorf WH (1971) Brain uptake of radiolabeled amino acids, amines, and hexoses after arterial injection. Am J Physiol 221(6):1629–1639PubMed
Zurück zum Zitat Pardo B, Rodrigues TB, Contreras L, Garzón M, Llorente-Folch I, Kobayashi K, Saheki T, Cerdan S, Satrústegui J (2011) Brain glutamine synthesis requires neuronal-born aspartate as amino donor for glial glutamate formation. J Cereb Blood Flow Metab 31(1):90–101PubMedCentralPubMedCrossRef Pardo B, Rodrigues TB, Contreras L, Garzón M, Llorente-Folch I, Kobayashi K, Saheki T, Cerdan S, Satrústegui J (2011) Brain glutamine synthesis requires neuronal-born aspartate as amino donor for glial glutamate formation. J Cereb Blood Flow Metab 31(1):90–101PubMedCentralPubMedCrossRef
Zurück zum Zitat Pardridge WM, Oldendorf WH (1975) Kinetic analysis of blood brain barrier transport of amino acids. Biochim Biophys Acta 401:128–134PubMedCrossRef Pardridge WM, Oldendorf WH (1975) Kinetic analysis of blood brain barrier transport of amino acids. Biochim Biophys Acta 401:128–134PubMedCrossRef
Zurück zum Zitat Price MT, Olney JW, Lowry OH, Buchsbaum S (1981) Uptake of exogenous glutamate and aspartate by circumventricular organs but not other regions of brain. J Neurochem 36(5):1774–1780PubMedCrossRef Price MT, Olney JW, Lowry OH, Buchsbaum S (1981) Uptake of exogenous glutamate and aspartate by circumventricular organs but not other regions of brain. J Neurochem 36(5):1774–1780PubMedCrossRef
Zurück zum Zitat Price KE, Pearce RE, Garg UC, Heese BA, Smith LD, Sullivan JE, Kennedy MJ, Bale JF Jr, Ward RM, Chang TK, Abbott FS, Leeder JS (2011) Effects of valproic acid on organic acid metabolism in children: a metabolic profiling study. Clin Pharmacol Ther 89(6):867–874PubMedCrossRef Price KE, Pearce RE, Garg UC, Heese BA, Smith LD, Sullivan JE, Kennedy MJ, Bale JF Jr, Ward RM, Chang TK, Abbott FS, Leeder JS (2011) Effects of valproic acid on organic acid metabolism in children: a metabolic profiling study. Clin Pharmacol Ther 89(6):867–874PubMedCrossRef
Zurück zum Zitat Rowley HL, Martin KF, Marsden CA (1995) Determination of in vivo amino acids neurotransmitters by high-performance liquid chromatography with o-phthalaldehyde-sulphate derivatisation. J Neurosci Methods 57:93–99PubMedCrossRef Rowley HL, Martin KF, Marsden CA (1995) Determination of in vivo amino acids neurotransmitters by high-performance liquid chromatography with o-phthalaldehyde-sulphate derivatisation. J Neurosci Methods 57:93–99PubMedCrossRef
Zurück zum Zitat Smith QR (2000) Transport of glutamate and other amino acids at the blood–brain barrier. J Nutr 130(4S Suppl):1016–1022 Smith QR (2000) Transport of glutamate and other amino acids at the blood–brain barrier. J Nutr 130(4S Suppl):1016–1022
Zurück zum Zitat Szyndler J, Maciejak P, Turzyńska D, Sobolewska A, Lehner M, Taracha E, Walkowiak J, Skórzewska A, Wisłowska-Stanek A, Hamed A, Bidziński A, Płaźnik A (2008) Changes in the concentration of amino acids in the hippocampus of pentylenetetrazole-kindled rats. Neurosci Lett 439(3):245–249PubMedCrossRef Szyndler J, Maciejak P, Turzyńska D, Sobolewska A, Lehner M, Taracha E, Walkowiak J, Skórzewska A, Wisłowska-Stanek A, Hamed A, Bidziński A, Płaźnik A (2008) Changes in the concentration of amino acids in the hippocampus of pentylenetetrazole-kindled rats. Neurosci Lett 439(3):245–249PubMedCrossRef
Zurück zum Zitat Szyndler J, Maciejak P, Turzyńska D, Sobolewska A, Walkowiak J, Płaźnik A (2012) The effects of electrical hippocampal kindling of seizures on amino acids and kynurenic acid concentrations in brain structures. J Neural Transm 119(2):141–149PubMedCentralPubMedCrossRef Szyndler J, Maciejak P, Turzyńska D, Sobolewska A, Walkowiak J, Płaźnik A (2012) The effects of electrical hippocampal kindling of seizures on amino acids and kynurenic acid concentrations in brain structures. J Neural Transm 119(2):141–149PubMedCentralPubMedCrossRef
Zurück zum Zitat Tcherkas YV, Kartsova LA, Krasnova IN (2001) Analysis of amino acids in human serum by isocratic reversed-phase high-performance liquid chromatography with electrochemical detection. J Chromatogr A 913:303–308PubMedCrossRef Tcherkas YV, Kartsova LA, Krasnova IN (2001) Analysis of amino acids in human serum by isocratic reversed-phase high-performance liquid chromatography with electrochemical detection. J Chromatogr A 913:303–308PubMedCrossRef
Zurück zum Zitat VanDongen AM, VanErp MG, Voskuyl RA (1986) Valproate reduces excitability by blockage of sodium and potassium conductance. Epilepsia 27(3):177–182PubMedCrossRef VanDongen AM, VanErp MG, Voskuyl RA (1986) Valproate reduces excitability by blockage of sodium and potassium conductance. Epilepsia 27(3):177–182PubMedCrossRef
Zurück zum Zitat Watanabe A, Shiota T, Takei N, Fujiwara M, Nagashima H (1986) Ammonia detoxification by accelerated oxidation of branched chain amino acids in brains of acute hepatic failure rats. Biochem Med Metab Biol 35(3):367–375PubMedCrossRef Watanabe A, Shiota T, Takei N, Fujiwara M, Nagashima H (1986) Ammonia detoxification by accelerated oxidation of branched chain amino acids in brains of acute hepatic failure rats. Biochem Med Metab Biol 35(3):367–375PubMedCrossRef
Zurück zum Zitat Wu HQ, Baran H, Ungerstedt U, Schwarcz R (1992) Kynurenic acid in the quinolinate-lesioned rat hippocampus: studies in vitro and in vivo. Eur J Neurosci 4(12):1264–1270PubMedCrossRef Wu HQ, Baran H, Ungerstedt U, Schwarcz R (1992) Kynurenic acid in the quinolinate-lesioned rat hippocampus: studies in vitro and in vivo. Eur J Neurosci 4(12):1264–1270PubMedCrossRef
Zurück zum Zitat Yudkoff M, Daikhin Y, Lin ZP, Nissim I, Stern J, Pleasure D, Nissim I (1994) Interrelationships of leucine and glutamate metabolism in cultured astrocytes. J Neurochem 62(3):1192–1202PubMedCrossRef Yudkoff M, Daikhin Y, Lin ZP, Nissim I, Stern J, Pleasure D, Nissim I (1994) Interrelationships of leucine and glutamate metabolism in cultured astrocytes. J Neurochem 62(3):1192–1202PubMedCrossRef
Zurück zum Zitat Yudkoff M, Daikhin Y, Nelson D, Nissim I, Erecińska M (1996) Neuronal metabolism of branched-chain amino acids: flux through the aminotransferase pathway in synaptosomes. J Neurochem 66(5):2136–2145PubMedCrossRef Yudkoff M, Daikhin Y, Nelson D, Nissim I, Erecińska M (1996) Neuronal metabolism of branched-chain amino acids: flux through the aminotransferase pathway in synaptosomes. J Neurochem 66(5):2136–2145PubMedCrossRef
Zurück zum Zitat Zeise ML, Kasparow S, Zieglgänsberger W (1991) Valproate suppresses N-methyl-d-aspartate-evoked, transient depolarizations in the rat neocortex in vitro. Brain Res 544(2):345–348PubMedCrossRef Zeise ML, Kasparow S, Zieglgänsberger W (1991) Valproate suppresses N-methyl-d-aspartate-evoked, transient depolarizations in the rat neocortex in vitro. Brain Res 544(2):345–348PubMedCrossRef
Metadaten
Titel
Valproate Disturbs the Balance Between Branched and Aromatic Amino Acids in Rats
verfasst von
Piotr Maciejak
Janusz Szyndler
Karolina Kołosowska
Danuta Turzyńska
Alicja Sobolewska
Jerzy Walkowiak
Adam Płaźnik
Publikationsdatum
01.05.2014
Verlag
Springer US
Erschienen in
Neurotoxicity Research / Ausgabe 4/2014
Print ISSN: 1029-8428
Elektronische ISSN: 1476-3524
DOI
https://doi.org/10.1007/s12640-013-9441-0

Weitere Artikel der Ausgabe 4/2014

Neurotoxicity Research 4/2014 Zur Ausgabe

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Frühe Alzheimertherapie lohnt sich

25.04.2024 AAN-Jahrestagung 2024 Nachrichten

Ist die Tau-Last noch gering, scheint der Vorteil von Lecanemab besonders groß zu sein. Und beginnen Erkrankte verzögert mit der Behandlung, erreichen sie nicht mehr die kognitive Leistung wie bei einem früheren Start. Darauf deuten neue Analysen der Phase-3-Studie Clarity AD.

Viel Bewegung in der Parkinsonforschung

25.04.2024 Parkinson-Krankheit Nachrichten

Neue arznei- und zellbasierte Ansätze, Frühdiagnose mit Bewegungssensoren, Rückenmarkstimulation gegen Gehblockaden – in der Parkinsonforschung tut sich einiges. Auf dem Deutschen Parkinsonkongress ging es auch viel um technische Innovationen.

Demenzkranke durch Antipsychotika vielfach gefährdet

23.04.2024 Demenz Nachrichten

Wenn Demenzkranke aufgrund von Symptomen wie Agitation oder Aggressivität mit Antipsychotika behandelt werden, sind damit offenbar noch mehr Risiken verbunden als bislang angenommen.

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.